2025生命健康产业跨境合作·澳珠琴对话世界500强活动成功召开

Core Viewpoint - The event "2025 Cross-Border Cooperation in Life and Health Industry: A Dialogue with the World's Top 500" highlights China's commitment to fostering innovation and collaboration in the life and health sector, particularly in the Guangdong-Hong Kong-Macao Greater Bay Area, which is seen as a core cluster for industry development [1][2]. Group 1: Government Initiatives - The Investment Promotion Bureau emphasizes that China's economic stability and growth momentum remain unchanged, with a focus on attracting foreign investment through open and cooperative policies [1]. - Specific measures have been introduced to encourage research and development, expedite review and approval processes, and provide support for essential resources in the life and health industry [1]. - The Investment Promotion Bureau will continue to monitor opportunities in the Greater Bay Area's life and health industry and facilitate practical cooperation between enterprises [1]. Group 2: Regional Development - The Greater Bay Area is positioned as a key cluster for the life and health industry, benefiting from a complete industrial ecosystem, open policy framework, active capital markets, and extensive application scenarios [1]. - The region is welcoming global life and health enterprises to share in the new development opportunities presented by the Greater Bay Area [1]. Group 3: Industry Participation - Representatives from over 100 companies and institutions, including major players like Bayer, Pfizer, and GE Healthcare, participated in discussions about business operations and investment opportunities in China [2]. - The Zhuhai municipal departments addressed concerns related to the review and approval of innovative drugs, cross-border research and development, and the facilitation of cross-border financing [2].